Rezension: Marie-Anna Chevalier / Isabelle Ortega (Hg.): Élites chrétiennes et formes du pouvoir en Méditerranée centrale et orientale (XIIIe–XVe siècle) (rezensiert von Andreas Kistner)

Autor: Kistner, Andreas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c30db84abcde631a60c4c770424efc0

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.

Autor: Albach, Fredrik N.¹ (AUTHOR), Geier, Christian¹ (AUTHOR), Keicher, Christian¹ (AUTHOR), Posch, Maximilian G.¹ (AUTHOR), Schreiber, Stephan J.² (AUTHOR), Grütz, Gerald³ (AUTHOR), Akyüz, Levent³ (AUTHOR), Luo, Xiaodong⁴ (AUTHOR), Le-Halpere, Annaig⁵ (AUTHOR), Truffinet, Philippe⁵ (AUTHOR) Philippe.Truffinet@sanofi.com, Wagner, Frank¹ (AUTHOR)

Publikováno v: Neurology & Therapy. Dec2024, Vol. 13 Issue 6, p1607-1625. 19p.

Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma.

Autor: Rupani H; Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK., Busse WW; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Howarth PH; Global Medical, Global Specialty and Primary Care, GSK, Brentford, Middlesex, UK., Bardin PG; Monash Lung Sleep Allergy and Immunology, Monash University and Medical Centre and Hudson Institute, Melbourne, Victoria, Australia., Adcock IM; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK., Konno S; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Jackson DJ; Guy's Severe Asthma Centre, Guy's and St Thomas' Hospitals, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK.

Publikováno v: Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2589-2604. Date of Electronic Publication: 2024 Aug 01.

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma.

Autor: Yancey SW; 1Respiratory Therapeutic Area, GSK, 5 Moore Drive, PO Box 13398, Research Triangle Park, NC 27709 USA., Ortega HG; Respiratory US Medical Affairs, GSK, La Jolla, CA USA.; Present Address: GossamerBio, San Diego, CA USA., Keene ON; 3Clinical Statistics, GSK, Stockley Park, Middlesex UK., Bradford ES; 1Respiratory Therapeutic Area, GSK, 5 Moore Drive, PO Box 13398, Research Triangle Park, NC 27709 USA.

Publikováno v: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2019 Sep 03; Vol. 15, pp. 53. Date of Electronic Publication: 2019 Sep 03 (Print Publication: 2019).

Association of depressive symptoms with health status and markers of uncontrolled severe asthma.

Autor: Khurana S; From the Department of Medicine, Pulmonary Diseases and Critical Care, University of Rochester Medical Center, Rochester, New York., Lyness JM; Department of Psychiatry and Neurology, University of Rochester Medical Center, Rochester, New York., Mallett S; Clinical Statistics, GlaxoSmithKline (GSK), Stockley Park, Middlesex, United Kingdom., Nelsen LM; Value Evidence and Outcomes, GSK, Collegeville, Pennsylvania., Prazma CM; Respiratory Franchise, GSK, Research Triangle Park, North Carolina., Albers FC; Respiratory Franchise, GSK, Research Triangle Park, North Carolina., Forshag M; Respiratory United States Medical Affairs, GSK, Research Triangle Park, North Carolina., Llanos JP; Respiratory United States Medical Affairs, GSK, Research Triangle Park, North Carolina., Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, North Carolina., Ortega HG; Respiratory United States Medical Affairs, GSK, Research Triangle Park, North Carolina.

Publikováno v: Allergy and asthma proceedings [Allergy Asthma Proc] 2019 Jul 01; Vol. 40 (4), pp. 230-239.